Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Ductal × Tamoxifen × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 156 Carcinoma, Intraductal, Noninfiltrating 16 Breast Carcinoma In Situ 12 Neoplasm Metastasis 9 Ovarian Neoplasms 7 Breast Neoplasms, Male 7 Neoplasms 4 Prostatic Neoplasms 3 Inflammatory Breast Neoplasms 3 Glioblastoma 3 Breast Cancer Female 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Obesity 2 Hot Flashes 2 Fibroadenoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 ER+ Breast Cancer 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Sexuality 1 Risk Reduction Behavior 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Primary Breast Cancer 1 Premenopausal Breast Cancer 1

Interventions

talimogene laherparepvec 1 exemestane 1 Therapeutics 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Radiation, Ionizing 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡